Holistic approach for molecules' identification and optimisation for an effective drug discovery workflow
Healthcare Data analyses using state-of-the-art AI technologies for compounds' hit-to-lead generation and lead optimization for drug discovery
How can we help you?
Aomics GmbH is a deep-tech healthcare startup based in Europe, with its headquarters located in Frankfurt, Germany. Our focus is on utilising big biological data, deep learning, AI, and blockchain technologies to develop Immuno-Oncology and Immuno-Informatics Solutions.
- Identification of novel molecular drug targets using multi-omics data
- Use AI to identify the existing knowledge on these variations from our in-house databases
Would you like to start a project with us?
Reach out on the given number or write us an email for further queries regarding project requirements